ESCAPE Bio Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
ESCAPE Bio is a small biotechnology company based in South San Francisco, California, focused on the discovery and early development of therapies for genetically defined neurodegenerative diseases. The organization concentrates on central nervous system disorders with a genetic basis, pursuing a targeted, mechanism-driven approach to treatment development. Operating in the biotechnology research sector, the company positions itself in the preclinical space, aiming to translate genetic insights into potential CNS therapies. In December 2021, ESCAPE Bio announced the appointment of a Chief Financial Officer and Chief Business Officer, reflecting leadership changes as it advances its activities.